search
Back to results

Syphilis and HIV Point of Care Testing (POCT) in Saskatchewan (SHIVER)

Primary Purpose

Syphilis, HIV Infections

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Reveal Rapid TP (from MedMira)
Sponsored by
Wellness Wheel Medical Clinic
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional screening trial for Syphilis focused on measuring point of care testing

Eligibility Criteria

16 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: 1650 consecutive individuals > 16 years accessing STBBI testing at specific locations and able to provide informed consent. PLWH and persons who are syphilis positive may also eligible to participate. Exclusion Criteria: ° Less than 16 years, unable to provide signed informed consent (e.g., intoxicated)

Sites / Locations

  • Queen City Wellness PharmacyRecruiting
  • Wellness Wheel Medical ClinicRecruiting

Outcomes

Primary Outcome Measures

Syphilis-Comparison between point of care testing and serology testing for Syphilis and HIV
To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for syphilis POCT.
HIV- Comparison between point of care testing and serology testing for Syphilis and HIV
HIV- To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for HIV POCT.
Syphilis/HIV- Comparison between point of care testing and serology testing for Syphilis and HIV
Dual HIV/Syphilis-To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for dual syphilis and HIV POCT.

Secondary Outcome Measures

Time to diagnosis-Clinical utility of POCT for management and follow up of Syphilis and HIV
To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: Time to diagnosis
Evaluate the acceptability and feasibility of POCT for syphilis and HIV
To evaluate the acceptability and feasibility by using a patient experience survey of POCT among different populations for syphilis and HIV among at risk and/or hard to reach populations, specifically: Health care provider experiences of feasibility and acceptability of the POCT used in this pilot b) Client acceptability and experiences with POCT in this pilot c) Client preferences for test offered (syphilis only, HIV only, or dual test of HIV and syphilis
HIV-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.
To evaluate the acceptability and feasibility of HIV alone among at-risk and/or hard to reach populations
Dual HIV/Syphilis-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.
To evaluate the acceptability and feasibility of combined syphilis/HIV POCT among at-risk and/or hard to reach populations
Syphilis-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.
To evaluate the acceptability and feasibility of syphilis alone, among at-risk and/or hard to reach populations
Time to treatment-Clinical utility of POCT for management and follow up of Syphilis and HIV
To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically:Time to treatment
Number of contacts-Clinical utility of POCT for management and follow up of Syphilis and HIV
To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: Number of contacts exposed to untreated infections
Time to connection-Clinical utility of POCT for management and follow up of Syphilis and HIV
To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: For HIV diagnoses, time to connection to clinical provider for ongoing management of HIV.

Full Information

First Posted
April 19, 2023
Last Updated
May 8, 2023
Sponsor
Wellness Wheel Medical Clinic
Collaborators
CIHR Canadian HIV Trials Network, University of Saskatchewan, Saskatchewan Health Authority - Regina Area
search

1. Study Identification

Unique Protocol Identification Number
NCT05863117
Brief Title
Syphilis and HIV Point of Care Testing (POCT) in Saskatchewan
Acronym
SHIVER
Official Title
Syphilis and HIV Point of Care Testing (POCT) to Improve Access to Testing Among Inner City, Remote, Rural and Hard to Reach Populations in Saskatchewan
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 1, 2023 (Actual)
Primary Completion Date
July 2024 (Anticipated)
Study Completion Date
July 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wellness Wheel Medical Clinic
Collaborators
CIHR Canadian HIV Trials Network, University of Saskatchewan, Saskatchewan Health Authority - Regina Area

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical trial is to learn about Syphilis and HIV point of care testing among inner city, remote, rural and hard to reach populations in Saskatchewan. The main question[s] it aims to answer are: To evaluate the field diagnostic test performance (e.g. sensitivity, specificity, predictive values) of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for syphilis POCT, HIV POCT and dual syphilis and HIV POCT. To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: Time to diagnosis Time to treatment Number of contacts exposed to untreated infections For HIV diagnoses, time to connection to clinical provider for ongoing management of HIV To evaluate the acceptability and feasibility of POCT among different populations for syphilis and HIV among at risk and/or hard to reach populations, specifically: Health care provider experiences of feasibility and acceptability of the POCT used in this pilot Client acceptability and experiences with POCT in this pilot Client preferences for test offered (syphilis only, HIV only, or dual test of HIV and syphilis 4. To evaluate the acceptability and feasibility of syphilis alone, HIV alone or combined syphilis/HIV POCT among at-risk and/or hard to reach populations. Participants will be assessed for risk factors that may increase risk of infectious disease such as substance use and sexual habits. They will then be offered a choice of 1 of 3 POCT(Syphilis alone, HIV alone or a dual HIV/Syphilis test). Serology will be obtained for sexually transmitted and blood born infections (STBBI's) and then the point of care test (POCT) will be completed. Following the testing the participant will complete a short survey on their experience.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Syphilis, HIV Infections
Keywords
point of care testing

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
1650 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Diagnostic Test
Intervention Name(s)
Reveal Rapid TP (from MedMira)
Other Intervention Name(s)
INSTI HIV-1/2 HIV test, INSTI Multiplex HIV-1/2 Syphilis
Intervention Description
Point of care tests for HIV and Syphilis
Primary Outcome Measure Information:
Title
Syphilis-Comparison between point of care testing and serology testing for Syphilis and HIV
Description
To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for syphilis POCT.
Time Frame
12-18 months
Title
HIV- Comparison between point of care testing and serology testing for Syphilis and HIV
Description
HIV- To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for HIV POCT.
Time Frame
12-18 months
Title
Syphilis/HIV- Comparison between point of care testing and serology testing for Syphilis and HIV
Description
Dual HIV/Syphilis-To evaluate the field diagnostic test performance of finger prick whole blood point of care testing (POCT) when compared to standard serum based testing for dual syphilis and HIV POCT.
Time Frame
12-18 months
Secondary Outcome Measure Information:
Title
Time to diagnosis-Clinical utility of POCT for management and follow up of Syphilis and HIV
Description
To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: Time to diagnosis
Time Frame
12-18 months
Title
Evaluate the acceptability and feasibility of POCT for syphilis and HIV
Description
To evaluate the acceptability and feasibility by using a patient experience survey of POCT among different populations for syphilis and HIV among at risk and/or hard to reach populations, specifically: Health care provider experiences of feasibility and acceptability of the POCT used in this pilot b) Client acceptability and experiences with POCT in this pilot c) Client preferences for test offered (syphilis only, HIV only, or dual test of HIV and syphilis
Time Frame
12-18 months
Title
HIV-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.
Description
To evaluate the acceptability and feasibility of HIV alone among at-risk and/or hard to reach populations
Time Frame
12-18 months
Title
Dual HIV/Syphilis-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.
Description
To evaluate the acceptability and feasibility of combined syphilis/HIV POCT among at-risk and/or hard to reach populations
Time Frame
12-18 months
Title
Syphilis-Comparison of acceptability and feasibility by using a patient experience survey of syphilis alone, HIV alone and dual HIV/Syphilis point of care testing among different populations.
Description
To evaluate the acceptability and feasibility of syphilis alone, among at-risk and/or hard to reach populations
Time Frame
12-18 months
Title
Time to treatment-Clinical utility of POCT for management and follow up of Syphilis and HIV
Description
To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically:Time to treatment
Time Frame
12-18 months
Title
Number of contacts-Clinical utility of POCT for management and follow up of Syphilis and HIV
Description
To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: Number of contacts exposed to untreated infections
Time Frame
12-18 months
Title
Time to connection-Clinical utility of POCT for management and follow up of Syphilis and HIV
Description
To evaluate the clinical utility of POCT for the prompt management and public health follow up of syphilis and HIV cases as compared to usual testing, specifically: For HIV diagnoses, time to connection to clinical provider for ongoing management of HIV.
Time Frame
12-18 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 1650 consecutive individuals > 16 years accessing STBBI testing at specific locations and able to provide informed consent. PLWH and persons who are syphilis positive may also eligible to participate. Exclusion Criteria: ° Less than 16 years, unable to provide signed informed consent (e.g., intoxicated)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nikki Williamson, RN
Phone
1-306-526-7350
Email
nikki.williamson@wellnesswheelclinic.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Susanne Nicolay, RN
Phone
1-306-520-2846
Email
susanne.nicolay@wellnesswheelclinic.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stuart Skinner, MD
Organizational Affiliation
Saskatchewan Health Region
Official's Role
Principal Investigator
Facility Information:
Facility Name
Queen City Wellness Pharmacy
City
Regina
State/Province
Saskatchewan
ZIP/Postal Code
S4P 0H7
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sara Kozusko
Phone
(306) 522-2266
Email
skozusko@nbly.ca
Facility Name
Wellness Wheel Medical Clinic
City
Regina
State/Province
Saskatchewan
ZIP/Postal Code
S4T0L6
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Susanne Nicolay, RN
Phone
1-306-520-2846
Email
susanne.nicolay@wellnesswheelclinic.ca
First Name & Middle Initial & Last Name & Degree
Vicky Schultz, RN
Phone
1-306-520-3889
Email
viky.schultz@wellnesswheelclinic.ca

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Syphilis and HIV Point of Care Testing (POCT) in Saskatchewan

We'll reach out to this number within 24 hrs